Hoxton Financial’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | $277K | Hold |
216
| – | – | 0.14% | 63 |
|
|
2015
Q4 | $531K | Hold |
216
| – | – | 0.26% | 31 |
|
|
2015
Q3 | $239K | Buy |
216
+10
| +5% | +$11.1K | 0.11% | 67 |
|
|
2015
Q2 | $207K | Hold |
206
| – | – | 0.09% | 80 |
|
|
2015
Q1 | $209K | Buy |
206
+205
| +20,500% | +$208K | 0.09% | 77 |
|
|
2014
Q4 | $3K | Sell |
1
-11
| -92% | -$33K | ﹤0.01% | 294 |
|
|
2014
Q3 | $36K | Hold |
12
| – | – | 0.02% | 143 |
|
|
2014
Q2 | $47K | Buy |
12
+4
| +50% | +$15.7K | 0.02% | 136 |
|
|
2014
Q1 | $46K | Buy |
+8
| New | +$46K | 0.02% | 137 |
|